Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22)

American Heart Journal

Volumn 161, Issue 6, 2011, Pages

  Wilson, Sean R ^a   Sabatine, Marc S ^a   Wiviott, Stephen D ^a   Ray, Kausik K ^b   De Lemos, James A ^c   Zhou, Shanggen ^d   Rifai, Nader ^e   Cannon, Christopher P ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; METFORMIN; PRAVASTATIN; SULFONYLUREA; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT DURATION; UNSTABLE ANGINA PECTORIS;

EID: 79958111379     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.02.014     Document Type: Article

References (40)

1. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
2. B.M. Spiegelman, L. Choy, and G.S. Hotamisligil Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes J Biol Chem 268 1993 6823 6826 (Pubitemid 23105553)
3. G. Fantuzzi, and T. Mazzone Adipose tissue and atherosclerosis: exploring the connection Arterioscler Thromb Vasc Biol 27 2007 996 1003 (Pubitemid 46641984)
4. N. Ouchi, S. Kihara, and Y. Arita Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476 (Pubitemid 30005109)
5. A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol Metab 13 2002 84 89 (Pubitemid 36740452)
6. R. Shibata, K. Sato, and D.R. Pimentel Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103 (Pubitemid 41486832)
7. Y. Okamoto, S. Kihara, and N. Ouchi Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770 (Pubitemid 35396973)
8. N. Ouchi, S. Kihara, and Y. Arita Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063 (Pubitemid 32200177)
9. M. Kumada, S. Kihara, and S. Sumitsuji Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89 (Pubitemid 36091630)
10. N. Ouchi, M. Ohishi, and S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234 (Pubitemid 37093465)
11. Y. Arita, S. Kihara, and N. Ouchi Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898 (Pubitemid 34666104)
12. Y. Wang, K.S. Lam, and J.Y. Xu Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner J Biol Chem 280 2005 18341 18347 (Pubitemid 41389081)
13. K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599 (Pubitemid 30353893)
14. Y. Iwashima, T. Katsuya, and K. Ishikawa Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 43 2004 1318 1323 (Pubitemid 38691756)
15. J. Hulthe, L.M. Hulten, and B. Fagerberg Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study Metabolism 52 2003 1612 1614 (Pubitemid 38049281)
16. T. Pischon, C.J. Girman, and G.S. Hotamisligil Plasma adiponectin levels and risk of myocardial infarction in men JAMA 291 2004 1730 1737 (Pubitemid 38489895)
17. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762 (Pubitemid 41372115)
18. R. Schnabel, C.M. Messow, and E. Lubos Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
19. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
20. C.P. Cannon, C.H. McCabe, and R. Belder Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial Am J Cardiol 89 2002 860 861 (Pubitemid 34241468)
21. B.M. Scirica, C.P. Cannon, and M.S. Sabatine Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death Clin Chem 55 2009 265 273
22. M. Cnop, P.J. Havel, and K.M. Utzschneider Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469 (Pubitemid 36577787)
23. U. Salmenniemi, E. Ruotsalainen, and J. Pihlajamaki Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome Circulation 110 2004 3842 3848 (Pubitemid 40023983)
24. C. Weyer, T. Funahashi, and S. Tanaka Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 2001 1930 1935 (Pubitemid 32472900)
25. M. Ryo, T. Nakamura, and S. Kihara Adiponectin as a biomarker of the metabolic syndrome Circ J 68 2004 975 981 (Pubitemid 39540124)
26. J. Spranger, A. Kroke, and M. Mohlig Adiponectin and protection against type 2 diabetes mellitus Lancet 361 2003 226 228 (Pubitemid 36126226)
27. Y. Yamamoto, H. Hirose, and I. Saito Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clin Sci (Lond) 103 2002 137 142
28. T. Araki, M. Emoto, and M. Teramura Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin Metabolism 55 2006 996 1001 (Pubitemid 44026543)
29. K. Maeda, K. Okubo, and I. Shimomura cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289 (Pubitemid 26136463)
30. E. Cavusoglu, C. Ruwende, and V. Chopra Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 27 2006 2300 2309 (Pubitemid 44453573)
31. W. Koenig, N. Khuseyinova, and J. Baumert Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany J Am Coll Cardiol 48 2006 1369 1377 (Pubitemid 44436825)
32. N. Sattar, G. Wannamethee, and N. Sarwar Adiponectin and coronary heart disease: a prospective study and meta-analysis Circulation 114 2006 623 629 (Pubitemid 44252303)
33. R.S. Lindsay, H.E. Resnick, and J. Zhu Adiponectin and coronary heart disease: the Strong Heart Study Arterioscler Thromb Vasc Biol 25 2005 e15 e16
34. D.A. Lawlor, G. Davey Smith, and S. Ebrahim Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women J Clin Endocrinol Metab 90 2005 5677 5683 (Pubitemid 41415475)
35. F. Otsuka, S. Sugiyama, and S. Kojima Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease J Am Coll Cardiol 48 2006 1155 1162 (Pubitemid 44345143)
36. R. Wolk, P. Berger, and R.J. Lennon Association between plasma adiponectin levels and unstable coronary syndromes Eur Heart J 28 2007 292 298
37. M. von Eynatten, A. Hamann, and D. Twardella Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease Eur Heart J 29 2008 1307 1315 (Pubitemid 351768129)
38. G. Maiolino, M. Cesari, and D. Sticchi Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients J Clin Endocrinol Metab 93 2008 3333 3340
39. U.B. Pajvani, M. Hawkins, and T.P. Combs Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J Biol Chem 279 2004 12152 12162 (Pubitemid 38445780)
40. T. Pischon, G.S. Hotamisligil, and E.B. Rimm Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year Clin Chem 49 2003 650 652 (Pubitemid 36379531)